28 research outputs found
Prevalence of HSV-2 at enrolment, by gender and age-group, Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–2010.
<p>Prevalence of HSV-2 at enrolment, by gender and age-group, Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–2010.</p
Factors associated with HSV2 incidence among participants in Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–2010.
<p>Factors associated with HSV2 incidence among participants in Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–2010.</p
HSV-2 prevalence at enrolment, stratified by age group and gender, among participants in the Kisumu Incidence Cohort Study, Kisumu, Kenya 2007–2010.
<p>HSV-2 prevalence at enrolment, stratified by age group and gender, among participants in the Kisumu Incidence Cohort Study, Kisumu, Kenya 2007–2010.</p
Estimated HSV-2/ HIV prevalence rates at enrolment by age-group and gender.
<p>Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–2010</p
Probit analysis for Abbott dried blood spot viral load limit of detection.
<p>Limit of detection 1,222copies/mL, 95% CI (978.12, 1873.7).</p
HIV-1 RNA detection rates of dried blood spot (DBS) specimens paired with plasma specimens prepared from patient support centers in Nyanza, Kenya.
<p>(November 2012 to February 2013).</p
HIV-1 RNA detection rates of dried plasma spot (DPS) specimens paired with plasma specimens prepared from patient support centers in Nyanza, Kenya.
<p>(November 2012 to February 2013).</p
Comparisons between CAP/CTM dried blood spot and Abbott dried blood spot tests at different cut-offs using CAP/CTM plasma as the gold standard.
<p>Comparisons between CAP/CTM dried blood spot and Abbott dried blood spot tests at different cut-offs using CAP/CTM plasma as the gold standard.</p
Bland-Altman analyses to evaluate repeatability in HIV-1 viral load quantification in 40 detectable a) DBS b) DPS collected from patients visiting Nyanza patient support centers and tested with Abbott.
<p>The difference between the references Run 1 and the comparisons Run 2 were plotted against the average of the reference group.</p
Concordance correlation analyses of HIV-1 viral load (VL) quantification among plasma and dried plasma spot specimens collected from patients visiting Nyanza patient support centers and tested with CAP/CTM and Abbott.
<p><b>a)</b> CAP/CTM plasma vs. DPS VL; <b>b</b>) Abbott plasma vs. DPS VL.</p